PubMed Health⌕ Search

Biomedical subjects

Michael E DeBakey

Publications and source records attributed to Michael E DeBakey.

14 recordsLinked to original sources
PubMed2006

The role of government in health care: a societal issue.

The history of the role of government in health care is briefly reviewed and more fully discussed in the United States since the establishment of Medicare 40 years ago. Data and other evidence of the unintended consequences of this historic event are presented, identifying thorny and onerous issues that government has created, showing failed attempts at band-aid solutions, and suggesting that our present health care system is in disarray and cannot be rectified by the "incrementalism" approach. The establishment of a high-level commission jointly endorsed by the President of the United States and Congress is recommended to consider and analyze scrupulously all the components of our health care complex and provide a "roadmap" toward achieving a universal health care system that is culturally acceptable, affordable, and of optimal quality while avoiding its administration and total control by an ultimately rigid and unwieldy governmental or insurance-industry bureaucracy.

Academic Medical Centers↗
PubMed2005

Development of mechanical heart devices.

BACKGROUND: A succinct, historical review of developments in mechanical devices to assist the failing heart is provided. METHODS: A number of methods of mechanical devices to assist the failing heart are briefly assessed. Personal experimental and clinical studies of devices developed over several decades are presented. RESULTS: Findings and data of devices used in assisting the failing heart, including those developed by the author, are analyzed. CONCLUSIONS: On the basis of this review, the left ventricular assist device is believed to be the most effective. There is also reason to believe that the axial flow system has considerable advantages. This form of therapy has potentially great value for permanent use in some patients with intractable heart failure.

Circulatory Arrest, Deep Hypothermia Induced↗
PubMed2005

Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure.

Congestive heart failure poses a serious health risk to millions of Americans. Medical therapy for advanced stages of this condition has offered a minimal benefit and surgical treatment through transplantation is limited by the donor organ shortage. Although left ventricular assist devices may represent the future of therapy for this disease, the first generation of these pumps are limited by a number of factors that restrict their use to only the sickest of patients. The development and clinical use of the MicroMed DeBakey VAD represents a paradigm shift in the field of heart disease, supporting the notion that mechanical assistance can be achieved with continuous flow pumps. Axial flow devices, such as the DeBakey VAD, may open new doors for smaller patients and children, as well as improve the current standard of care for adults who require long-term circulatory support.

Chronic Disease↗
PubMed2004

International Center for Medical Technologies acknowledges Artificial Organ Pioneers at the ASAIO-ISAO Joint Congress in 2003.

The International Center for Medical Technologies (ICMT), a museum for artificial organs in Houston, Texas, officially opened in November 2002, as previously published in Artificial Organs 2003;27(9):821-32. The museum expanded its original activities to formulate the International Academy for Artificial Organ Pioneers (Academy) and the International Faculty for Health and Medical Technologies (Faculty). At the joint American Society for Artificial Internal Organs (ASAIO) and International Society for Artificial Organs (ISAO) Congress in Washington, DC on June 18, 2003, Yukihiko Nosé introduced the ICMT and its formulation. The activities and future perspectives were presented by the ICMT Museum Director, Steven Phillips; the Academy Dean, Lowell Harmison; and the Faculty Dean, Michael E. DeBakey.

Academies and Institutes↗
PubMed2003

Surgical outcome in 85 patients with primary cardiac tumors.

BACKGROUND: We present a large, single institution experience with adult cardiac tumors and address factors affecting outcome. METHODS: A retrospective review was made of all patients who underwent surgery for primary cardiac tumors from April 1975 through August 2002. RESULTS: Eighty-five patients (33 male and 52 female) with a mean age of 54 years were identified with follow-up available for 80 (94%) patients. There were 68 (80%) benign tumors and 17 (20%) malignant tumors. Three tumors recurred and were resected giving a total of 88 surgeries. All benign tumors were grossly resected and the extent of resection for malignant disease ranged from 14 (78%) gross resections and 3 (17%) debulkings to 1 (5%) biopsy. There were 4 (5%) early hospital deaths. Median survival was 9.6 months and 322 months for patients with malignant and benign diseases, respectively. Significant predictors of long-term mortality were malignant disease (P <0.0001) and New York Heart Association class (P <0.03). CONCLUSIONS: Surgical resection provides excellent outcome in patients with benign cardiac tumors. Malignant tumors continue to pose a challenge with good local tumor control but limited survival owing to metastatic disease.

Adolescent↗